SLS:NASDAQ
Sellas Life Sciences Group Inc
$11.54
arrow_downward
-14.42%(-1.94) 1D
$11.29
arrow_downward
-2.21% (-0.26)todayPre-market
Closed: Sep 11, 4:00:00âŻPM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLS...
Open
$13.55
High
$13.74
Low
$11.38
Mkt. cap
2.33B
Avg. vol.
6.55M
Volume
26.49K
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
Open
$13.55
High
$13.74
Low
$11.38
Mkt. cap
2.33B
Avg. vol.
6.55M
Volume
26.49K
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
News stories
From web sources and news partners
TechStock²
·
2 days ago
Why Did SLS Stock Fall 14%? No New Filing, but Two Binary Catalysts Loom
TipRanks
·
2 days ago
Legal Probes And Dilution Fears Hammer Sellas Stock
Simply Wall Street
·
2 days ago
How Investors May Respond To SELLAS Life Sciences Group (SLS) Phase 3 Trial Nears
https://www.dars.gov.et/
·
3 weeks ago
SELLAS (SLS) Quarterly Results: EPS Comes in Below Forecast in Latest Trading; The Stock Gains 5.00% at the Close
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorBiotechnology
Websitesellaslifesciences.com